SITAGLIPTINE/METFORMINE ALTER 50 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 60 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930261187
  • CIP7 3026118
  • CIS 61293226

What the source publishes

Holder
LABORATOIRES ALTER
Active ingredients
SITAGLIPTINE, CHLORHYDRATE DE METFORMINE, CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ
Form
comprimé pelliculé
Package
plaquette(s) PVC PVDC aluminium de 60 comprimé(s)
Routes
orale
Administrative status
cancelled
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2020-02-17
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930261187
{
  "cis": "61293226",
  "cip7": "3026118",
  "form": "comprimé pelliculé",
  "name": "SITAGLIPTINE/METFORMINE ALTER 50 mg/1000 mg, comprimé pelliculé — plaquette(s) PVC PVDC aluminium de 60 comprimé(s)",
  "cip13": "3400930261187",
  "holder": "LABORATOIRES ALTER",
  "routes": [
    "orale"
  ],
  "holders": [
    "LABORATOIRES ALTER"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "9.20",
  "authorisedOn": "2020-02-17",
  "compositions": [
    {
      "name": "SITAGLIPTINE",
      "nature": "FT",
      "strength": "50 mg",
      "linkageNumber": "1",
      "substanceCode": "20740",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE METFORMINE",
      "nature": "SA",
      "strength": "1000 mg",
      "linkageNumber": "2",
      "substanceCode": "24321",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    },
    {
      "name": "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "85939",
      "dosageReference": null,
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "8.18",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "SITAGLIPTINE/METFORMINE ALTER 50 mg/1000 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-11-20",
    "CIS_CIP_bdpm": "2026-11-20",
    "CIS_CPD_bdpm": "2026-11-20",
    "CIS_COMPO_bdpm": "2026-11-20"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "plaquette(s) PVC PVDC aluminium de 60 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "30 %"
  ],
  "marketingDeclaredOn": "2024-03-01",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SITAGLIPTINE",
    "CHLORHYDRATE DE METFORMINE",
    "CHLORHYDRATE DE SITAGLIPTINE MONOHYDRATÉ"
  ],
  "authorisationProcedure": "Procédure décentralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930261187"